Analysts Estimate Cinemark Holdings (CNK) to Report a Decline in Earnings: What to Look Out for
The market expects Cinemark Holdings (CNK) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on May 2, 2025, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
This movie theater owner is expected to post quarterly loss of $0.22 per share in its upcoming report, which represents a year-over-year change of -215.8%.
Revenues are expected to be $553.82 million, down 4.4% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 8.65% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
For Cinemark, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -34.26%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Cinemark will beat the consensus EPS estimate.
Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Cinemark would post earnings of $0.39 per share when it actually produced earnings of $0.33, delivering a surprise of -15.38%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Cinemark doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Another stock from the Zacks Film and Television Production and Distribution industry, Live Nation (LYV), is soon expected to post loss of $0.27 per share for the quarter ended March 2025. This estimate indicates a year-over-year change of +49.1%. Revenues for the quarter are expected to be $3.5 billion, down 7.8% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Live Nation has been revised 1.4% down to the current level. Nevertheless, the company now has an Earnings ESP of -39.03%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that Live Nation will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cinemark Holdings Inc (CNK) : Free Stock Analysis Report
Live Nation Entertainment, Inc. (LYV) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Is ZIM Stock's Cheap Valuation Reason Enough to Bet on it?
ZIM Integrated Shipping ZIM shares are one of the cheaper ones in the Zacks Transportation-Shipping industry, with a Value Score of A. ZIM stock is trading at a significant discount, with a forward 12-month P/S of 0.32X compared with the industry's 1.95X. ZIM is also cheaper than other shipping stocks like Star Bulk Carriers SBLK and Euroseas ESEA. Star Bulk Carriers and Euroseas have a Value Score of B each. Image Source: Zacks Investment Research ZIM's cheap valuation is attractive for investors. However, is it worth buying at current prices? Let's dig deep to find out. ZIM has an asset-light model, which means that the focus is more on leasing rather than owning vessels. This allows it to adjust capacity rapidly in response to market changes. ZIM's focus on niche markets and high-margin trade routes helps it avoid crowded, low-margin segments, thereby maintaining strong pricing power. This, too, aids profitability. The shipping company's operational efficiency is being aided by investments in digitalization and innovative technologies. ZIM's shareholder-friendly approach reflects its financial prosperity. The shipping company's high dividend yield is a huge positive for income-seeking investors. This highlights confidence in its cash flow and prospects. In the December quarter, ZIM's board declared a regular dividend of approximately $382 million or $3.17 per ordinary share. In the first quarter of 2025, ZIM's board of directors declared a regular cash dividend of approximately $89 million, or 74 cents per share, reflecting approximately 30% of the quarter's net income. In its recently released first-quarter 2025 results, ZIM continued its streak of beating earnings expectations, showing resilience despite tough conditions. In fact, the shipping stock outpaced the Zacks Consensus Estimate for earnings in each of the last four quarters, with the average being 34.5%. ZIM Integrated Shipping Services price-eps-surprise | ZIM Integrated Shipping Services Quote Tariff Tensions: The ongoing trade tension does not bode well for ZIM, as the company has significant exposure to both China and the United States. Transpacific volumes have been suffering due to the trade woes hurting ZIM. Agreed that tariff woes are showing signs of easing, with the United States and China announcing a 90-day suspension on mutual tariffs; however, in the absence of a long-term trade deal, the scenario will continue to be uncertain. Even on the first-quarter conference call, management sounded cautious regarding transpacific trade during the remainder of 2025 in the absence of a longer-term agreement. Earnings Estimates Unimpressive for ZIM: The trade tensions are primarily responsible for the year-over-year decline in the 2025 and 2026 earnings estimates of this shipping stock. Image Source: Zacks Investment Research High Debt Load: We are concerned about ZIM's high debt levels. Long-term debt more than doubled to $4.7 billion at 2024-end from 2019. Image Source: Zacks Investment Research Unimpressive Price Performance of ZIM Stock: Shares of ZIM have not had a good run on the bourses so far this year, declining 19.6% compared with the industry's 4.8% fall. Star Bulk Carriers and Euroseas have performed much better year to date. Image Source: Zacks Investment Research There is no doubt that the stock is attractively valued. The company's shareholder-friendly initiatives also add to its appeal. However, the tariff-induced economic uncertainty clouds its near-term outlook. High debts also do not help matters. Given the current uncertainty, it is not at all advisable to buy this Zacks Rank #3 (Hold) stock. Investors should monitor the company's developments closely for an appropriate entry point. For those who already own the stock, it will be prudent to stay invested. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Star Bulk Carriers Corp. (SBLK) : Free Stock Analysis Report Euroseas Ltd. (ESEA) : Free Stock Analysis Report ZIM Integrated Shipping Services Ltd. (ZIM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
All You Need to Know About Annovis Bio (ANVS) Rating Upgrade to Buy
Investors might want to bet on Annovis Bio, Inc. (ANVS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements. Therefore, the Zacks rating upgrade for Annovis Bio basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. The change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock. Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Annovis Bio imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher. As empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions. The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> . For the fiscal year ending December 2025, this company is expected to earn -$1.52 per share, which is unchanged compared with the year-ago reported number. Analysts have been steadily raising their estimates for Annovis Bio. Over the past three months, the Zacks Consensus Estimate for the company has increased 9.8%. Unlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term. You can learn more about the Zacks Rank here >>> The upgrade of Annovis Bio to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Annovis Bio, Inc. (ANVS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
5 hours ago
- Yahoo
Commvault (CVLT) is an Incredible Growth Stock: 3 Reasons Why
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all. By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss. However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects. Commvault Systems (CVLT) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank. Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better. Here are three of the most important factors that make the stock of this data-management software company a great growth pick right now. Earnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration. While the historical EPS growth rate for Commvault is 32.1%, investors should actually focus on the projected growth. The company's EPS is expected to grow 13.1% this year, crushing the industry average, which calls for EPS growth of 12.4%. Cash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds. Right now, year-over-year cash flow growth for Commvault is 45.4%, which is higher than many of its peers. In fact, the rate compares to the industry average of 9.9%. While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 19.8% over the past 3-5 years versus the industry average of 10.5%. Beyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements. The current-year earnings estimates for Commvault have been revising upward. The Zacks Consensus Estimate for the current year has surged 1% over the past month. While the overall earnings estimate revisions have made Commvault a Zacks Rank #1 stock, it has earned itself a Growth Score of A based on a number of factors, including the ones discussed above. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. This combination indicates that Commvault is a potential outperformer and a solid choice for growth investors. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CommVault Systems, Inc. (CVLT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
